* Outset Medical Inc is expected to show a fall in quarterly revenue when it reports results on November 6 for the period ending September 30 2024
* The San Jose California-based company is expected to report a 11.4% decrease in revenue to $26.905 million from $30.36 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.
* LSEG's mean analyst estimate for Outset Medical Inc is for a loss of 42 cents per share.
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street's median 12-month price target for Outset Medical Inc is 3.00, above its last closing price of $0.61.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jan. 1 0001 -0.45 -0.45 -0.47 Missed -4.1
Dec. 31 0001 -0.56 -0.55 -0.57 Missed -3.9
Jan. 1 0001 -0.67 -0.61 -0.59 Beat 4.1
Jan. 1 0001 -0.67 -0.67 -6.5
Jun. -0.84 -0.76 -18
30 2023
Jan. 1 0001 -0.78 -0.74 -0.90 Missed -21.3
Dec. 31 2022 -0.91 -0.86 -0.86 Met 0
Jan. 1 0001 -0.84 -0.81 -0.85 Missed -4.9
This summary was machine generated November 4 at 21:14 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。